Det anbefales, at antiarytmisk behandling for bradykardi og/ eller ventrikulær takyarytmier (pacemaker, defibrillator) skal være tilgængelig når Metalyse administreres.
It is recommended that antiarrhythmic therapy for bradycardia and/ or ventricular tachyarrhythmias (pacemaker, defibrillator) be available when Metalyse is administered.